Beihai Gofar Chuanshan Biological Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001DD2
CNY
6.36
-0.11 (-1.7%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
337.29
365.72
456.09
421.05
265.20
248.52
221.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
337.29
365.72
456.09
421.05
265.20
248.52
221.14
Raw Material Cost
262.87
284.05
338.55
323.80
205.33
208.99
187.04
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
34.17
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.48
0.45
0.56
0.72
0.22
0.17
0.27
Selling and Distribution Expenses
84.79
90.93
85.20
78.17
56.50
51.58
61.91
Other Expenses
0.47
1.13
0.71
0.80
-0.02
-0.01
-3.42
Total Expenditure (Excl Depreciation)
354.83
386.69
431.38
410.66
261.89
260.65
249.21
Operating Profit (PBDIT) excl Other Income
-17.5
-21
24.700000000000003
10.4
3.3000000000000003
-12.1
-28.1
Other Income
-1.15
4.87
5.46
8.06
8.42
25.53
9.67
Operating Profit (PBDIT)
-3.05
-3.37
43.73
31.24
23.28
27.79
-4.46
Interest
2.48
0.45
0.56
0.72
0.22
0.17
0.27
Exceptional Items
-60.37
-49.59
-0.25
0.13
1.00
0.83
-0.77
Gross Profit (PBDT)
74.42
81.67
117.54
97.25
59.86
39.53
34.09
Depreciation
16.53
14.26
14.29
13.76
12.69
16.58
14.43
Profit Before Tax
-82.43
-67.67
28.64
16.89
11.38
11.88
-19.92
Tax
-0.07
3.59
5.46
5.86
6.37
4.64
0.45
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-93.85
-82.31
34.84
10.49
3.20
5.77
-21.61
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-93.85
-82.31
34.84
10.49
3.20
5.77
-21.61
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.94
1.15
1.81
-0.56
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-91.91
-81.16
36.65
9.93
3.20
5.77
-21.61
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
775.39
869.24
951.55
916.70
844.42
645.61
637.56
Earnings per share (EPS)
-0.18
-0.16
0.07
0.02
0.01
0.01
-0.05
Diluted Earnings per share
-0.18
-0.16
0.07
0.02
0.01
0.01
-0.05
Operating Profit Margin (Excl OI)
-5.47%
-6.15%
5.26%
2.24%
0.82%
-5.76%
-12.91%
Gross Profit Margin
-19.54%
-14.6%
9.41%
7.28%
9.08%
11.45%
-2.48%
PAT Margin
-27.82%
-22.51%
7.64%
2.49%
1.21%
2.32%
-9.77%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -7.77% vs -19.82% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -13.18% vs -321.86% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 76.83% vs -121.41% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 400.00% vs -16.67% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Beihai Gofar Chuanshan Biological Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
337.29
0
337.29
Other Operating Income
0.00
0.00
0.00
Total Operating income
337.29
0
337.29
Raw Material Cost
262.87
0
262.87
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.48
0
2.48
Selling and Distribution Expenses
84.79
0
84.79
Other Expenses
0.47
0.00
0.47
Total Expenditure (Excl Depreciation)
354.83
0
354.83
Operating Profit (PBDIT) excl Other Income
-17.54
0.00
-17.54
Other Income
-1.15
0
-1.15
Operating Profit (PBDIT)
-3.05
0
-3.05
Interest
2.48
0
2.48
Exceptional Items
-60.37
0
-60.37
Gross Profit (PBDT)
74.42
0
74.42
Depreciation
16.53
0
16.53
Profit Before Tax
-82.43
0
-82.43
Tax
-0.07
0
-0.07
Provisions and contingencies
0
0
0.00
Profit After Tax
-93.85
0
-93.85
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-93.85
0
-93.85
Share in Profit of Associates
0
0
0.00
Minority Interest
1.94
0
1.94
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-91.91
0
-91.91
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
775.39
0
775.39
Earnings per share (EPS)
-0.18
0
-0.18
Diluted Earnings per share
-0.18
0
-0.18
Operating Profit Margin (Excl OI)
-5.47%
0%
0.00
-5.47%
Gross Profit Margin
-19.54%
0%
0.00
-19.54%
PAT Margin
-27.82%
0%
0.00
-27.82%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 33.73 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -7.77% vs -19.82% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit -9.19 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -13.18% vs -321.86% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.19 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 76.83% vs -121.41% in Dec 2023

Annual - Interest
Interest 0.25 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 400.00% vs -16.67% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -5.47%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023